USA – Starlight Cardiovascular, a San Diego, CA-based preclinical stage medical technology company, raised $9.48M in Series A funding.
The round, which included conversion of previously-issued notes, was led by Bird B.The company intends to use the funds to progress development of its portfolio of pediatric interventional cardiology devices.Led by CEO Beverly Tang and Co-founder Dr. Pedro del Nido, Chairman of Cardiac Surgery at Boston Children’s Hospital, Starlight Cardiovascular is a preclinical stage medical technology company developing a portfolio of devices to address pediatric Congenital Heart Disease. Its first product, a Ductus Arteriosus Stent, replaces a life-saving open chest surgery with a microcatheter-based procedure performed through a small incision in the skin.05/10/2022
